About

Mark A. Buthman is an independent director of IDEX who brings extensive global financial and operational leadership experience from a 33-year career at Kimberly-Clark, a multinational Fortune 150 company. During 12 years as Kimberly-Clark's Executive Vice President and Chief Financial Officer he was part of an executive team that created more than $20 billion in shareholder value and developed deep expertise in large, complex M&A transactions, corporate finance and capital allocation.

At Kimberly-Clark he executed or oversaw more than 50 acquisitions, including the $9.4 billion merger with Scott Paper Company and the tax-free spin-offs of Halyard Health and the Neenah Paper business. Mr. Buthman holds a B.B.A. in Business Management from the University of Iowa.

Roles

Idex Corp.
Independent Director; Audit Committee (Chair), Nominating and Corporate Governance Committee · Current role
2016–present
Kimberly-Clark Corporation (NYSE: KMB)
Executive Vice President and Chief Financial Officer · Also held roles including Vice President of Finance and Vice President of Strategic Planning and Analysis
2003 - 2015

External Roles

West Pharmaceutical Services, Inc. (NYSE: WST)
Independent Director
2010 - Present
Pavillon International
Vice Chairman of the Board of Directors
—

Director Compensation

FY 2025
Fees earned or paid in cash
$115,000
Stock awards
$165,262
Total
$280,262

Also at Idex Corp.

Related

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.